aripiprazole lauroxil extended release injection gained fda approval in 2015 as a treatment for adults suffering from schizophrenia. like any long-term acting injectable, aripiprazole lauroxil provides assurance to families and health care professionals that patients receive therapeutic medication throughout the day.